PATH founder files Form 144 for $12.9M stock sale
Rhea-AI Filing Summary
UiPath, Inc. (PATH) filed a Form 144 reporting a proposed sale of 1,000,000 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $12,900,000. The filing states these are founders' shares acquired on 04/21/2021 and indicates the sale is expected on or about 10/06/2025 on the NYSE. The filer represents no undisclosed material information and notes prior Rule 10b5-1 program sales totaling multiple transactions in the past three months, including repeated daily lots of 122,733 shares and several blocks of 45,000 shares, producing gross proceeds listed per trade. The notice identifies total shares outstanding as 453,568,899, which frames the proposed sale as a small fraction of the outstanding base.
Positive
- Sale size is modest at 1,000,000 shares (~0.22% of outstanding)
- Seller used Rule 10b5-1 program previously, showing pre-arranged trading activity
Negative
- Founder share sale could marginally increase free float and selling pressure around 10/06/2025
Insights
TL;DR: A founder sale under Rule 144 is planned and prior 10b5-1 sales were executed recently.
The filing records a proposed sale of $12,900,000 worth of common stock (1,000,000 shares) sourced from founders' shares acquired on 04/21/2021. The transaction is routed through Morgan Stanley Smith Barney LLC and scheduled for 10/06/2025, with trades expected on the NYSE.
Compliance-wise, the notice includes the required representation that the seller is unaware of undisclosed material information and documents a history of Rule 10b5-1 sales in the prior three months. Watch for filings confirming execution details and any updates to the 10b5-1 plan timing within the next few trading days.
TL;DR: Sale size is modest relative to the share base but will increase circulating float slightly.
The proposed 1,000,000-share sale represents roughly 0.22% of the reported 453,568,899 shares outstanding, so the direct dilution or float increase is small in percentage terms. Prior 10b5-1 sales listed show repeated daily lots of 122,733 shares and blocks of 45,000 shares that have already generated multi-million dollar proceeds.
Investors may monitor short-term volume and any further insider dispositions; near-term impact is likely limited given the small percentage of outstanding shares, but execution timing could influence daily trading volumes around 10/06/2025.